BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin

Nisha Bansal(Moffitt Cancer Center), Johnathan M. Lancaster(Moffitt Cancer Center)
Journal of Gynecologic Oncology
January 1, 2012
Cited by 26


Related Papers